Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise: Job title: Surgical Director, Mitral and Tricuspid Therapies
Surgical Director, Mitral and Tricuspid Therapies at NewYork-Presbyterian/ Columbia University Medical Center. Dr. Bapat is also an assistant professor of surgery at CUMC.Dr. Bapat specializes in the minimally invasive and percutaneous treatment of structural heart disease with a focus on mitral and tricuspid therapies.Dr. Bapat did a fellowship program at Royal College of Surgeons in Edinburgh… View more
Author(s): Pavel Overtchouk , Thomas Modine Added: 3 years ago
This article aims to provide an updated comparative review, addressing the respective strengths and weaknesses of different alternative transcatheter aortic valve implantation (TAVI) approaches. The transfemoral (TF) access is favoured by international guidelines on TAVI because of its reported superiority to the transthoracic approach.1–3 In spite of the progress in miniaturisation of new… View more
Author(s): Alia Noorani , Vinayak Bapat Added: 3 years ago
Transcatheter aortic valve implantation (TAVI) is an established alternative to surgical valve replacement in the management of calcified severe aortic stenosis in those with co-morbidities or adverse features (advanced age, impaired left ventricular function), or in those where open surgery may be associated with unfavourable technical features, such as previous sternotomy with a patent internal… View more
Author(s): Luca Testa , Azeem Latib Added: 3 years ago
Leaflet motion abnormalities (LMAs) are a relatively new entity in the field of transcatheter aortic valves (TAVs).1–4 They can be associated with the thrombosis of the bioprosthesis (TAVT), often leading to dramatic clinical scenarios1 or, on the other hand, they can result in a hypoattenuated leaflet thickening (HALT) and/or reduced leaflet motion (RELM), both usually associated with gradients… View more
Author(s): Kendra J Grubb , Tamim Nazif , Mathew R Williams , et al Added: 3 years ago
Concomitant coronary artery disease (CAD) and valvular heart disease is a common problem in the ageing population. It is estimated that the prevalence of mitral regurgitation and aortic stenosis in individuals over the age of 70 is 10 % and 4 %, respectively.1,2 Among patients presenting with symptomatic aortic stenosis, concurrent CAD occurs in over 50 % of those over 70 years of age and over 65… View more